- memo-therapeutics.com
- 3
- 3
- 16
Memo Therapeutics AG ("MTx") is a late-stage biotech company developing best-in-class therapeutic antibodies to transform the lives of patients with virus infections and cancer. MTx' lead program, AntiBKV, is a highly effective and safe neutralizing..
Relevance: 11.81906